Baird Medical Investment Holdings Limited BDMD
0.13 USD +0.02 (+21.82%)
Nov 5, 2026, 1:59 PM EST
0.1003 Day range 0.1945
0.073 52-week range 3.70
- YTD
- -90.43%
- 1 year
- -88.88%
- Market cap
- 4.16M
- Revenue (ttm)
- 33.05M
- Profit margin
- 37.96%
- EPS (ttm)
- -0.55
- Shares out
- 35.78M
- YTD return
- -90.43%
- 1-year return
- -88.88%
- Volume
- 305.04M
- Avg volume
- 3.37M
- Open
- 0.102
- Previous close
- 0.1068
- Day's range
- 0.1003 – 0.1945
- 52-week range
- 0.073 – 3.70
- Beta
- 0.14
5D -0.0549 (-29.00%)
Key statistics
- Enterprise value
- 67.68M
- PEG ratio
- 0.00
- Price / sales
- 1.91
- Price / book
- 1.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 13.80%
- Free cash flow
- 0
- Total cash
- 1.66M
- Total debt
- 15.52M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 2.51
- 200-day average
- 8.62
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
BDMD Revenue — quarterly 31.46M
BDMD Net income — quarterly 13.13M
BDMD EPS — quarterly 0.66
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- China
- Website
- bairdmed.com
News
Baird Medical Investment Holdings' Partner Tianjin Yuanshan Medical Technology Files Premarket Notification With FDA, Application For CE Conformity Assessment In EU For Irreversible Electroporation System 
Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System 
Baird Medical Investment Holdings Receives Nasdaq Noncompliance Notice, Gets Time Through May 3, 2027 To Regain Compliance 
Baird Medical Issues Statement Regarding Recent Share Price Volatility 
Baird Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
Why Limbach Holdings Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - 12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's Intraday Session - 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Your note
Sign in to keep a note on BDMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| EXCELFIN SPAC LLC | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Oct 24, 2023 | 0 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | May 10, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.02% | 5,852 | 10.33K | Oct 30, 2024 |